Akshamal M. Gamage
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akshamal M. Gamage has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Jing Liu
Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
1 shared publication - Kai Sen Tan
Infectious Diseases Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
1 shared publication
Latest Publications
- 14 May 2022
- Published by Springer Nature
- Vol. 2452, 213-224
Human Nasal Epithelial Cells (hNECs) Generated by Air-Liquid Interface (ALI) Culture as a Model System for Studying the Pathogenesis of SARS-CoV-2
The nasal epithelium lining the human upper airway is the primary portal of entry for several respiratory pathogens, including the recently emerged SARS-CoV-2 virus responsible for the ongoing COVID-19 pandemic. Here, we describe in detail methods for in vitro ALI differentiation of primary cells collected from human donors, to obtain differentiated hNECs. This can serve as a physiologically relevant model to investigate various aspects of host–pathogen responses to SARS-CoV-2 and other emerging respiratory viruses.
- 14 May 2022
- Published by Springer Nature
- Vol. 2452, 213-224
Human Nasal Epithelial Cells (hNECs) Generated by Air-Liquid Interface (ALI) Culture as a Model System for Studying the Pathogenesis of SARS-CoV-2
The nasal epithelium lining the human upper airway is the primary portal of entry for several respiratory pathogens, including the recently emerged SARS-CoV-2 virus responsible for the ongoing COVID-19 pandemic. Here, we describe in detail methods for in vitro ALI differentiation of primary cells collected from human donors, to obtain differentiated hNECs. This can serve as a physiologically relevant model to investigate various aspects of host–pathogen responses to SARS-CoV-2 and other emerging respiratory viruses.